McKinley Capital Management’s Insys Therapeutics, Inc. INSY Stock Holding History

McKinley Capital Management’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-160,585	Closed	-$2.08M	–	614
2016 Q2	$2.08M	Sell	160,585 -43	-0%	-$627	0.1%	189
2016 Q1	$2.57M	Buy	160,628 +79,188	+97%	+$1.5M	0.12%	158
2015 Q4	$2.33M	Buy	81,440 +56	+0.1%	+$1.55K	0.11%	170
2015 Q3	$2.32M	Sell	81,384 -47	-0.1%	-$1.73K	0.11%	170
2015 Q2	$2.92M	Sell	81,431 -133	-0.2%	-$4.14K	0.13%	177
2015 Q1	$2.37M	Buy	+81,564	New	+$2.16M	0.1%	189

Other funds holding INSY

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FHAM

Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

McKinley Capital Management's INSY Position: Q3 2016 in Review

McKinley Capital Management sold out of Insys Therapeutics, Inc. (INSY) in Q3 2016, closing a stake of 160,585 shares — an estimated $2.08M sold.

McKinley Capital Management first reported a position in INSY in Q1 2015 and held it in 6 quarters. The position peaked at $2.92M in Q2 2015. 138 funds tracked by Wall St. Rank hold INSY as of Q3 2016.

McKinley Capital Management reported no remaining Insys Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
McKinley Capital Management sold 160,585 Insys Therapeutics, Inc. shares in Q3 2016, an estimated $2.08M.
McKinley Capital Management first reported a position in Insys Therapeutics, Inc. in Q1 2015 and held it in 6 quarters.
McKinley Capital Management's Insys Therapeutics, Inc. position peaked at $2.92M in Q2 2015.
138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2016.

Based on McKinley Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.